Keurig Dr Pepper Interest Paid decreased by 55.3% to $97.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.3%, from $93.00M to $97.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 5.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $230.00M | $25.00M | $193.00M | $27.00M | $181.00M | $28.00M | $127.00M | $39.00M | $192.00M | $24.00M | $188.00M | $24.00M | $187.00M | $97.00M | $186.00M | $93.00M | $184.00M | $100.00M | $217.00M | $97.00M |
| QoQ Change | — | -89.1% | +672.0% | -86.0% | +570.4% | -84.5% | +353.6% | -69.3% | +392.3% | -87.5% | +683.3% | -87.2% | +679.2% | -48.1% | +91.8% | -50.0% | +97.8% | -45.7% | +117.0% | -55.3% |
| YoY Change | — | — | — | — | -21.3% | +12.0% | -34.2% | +44.4% | +6.1% | -14.3% | +48.0% | -38.5% | -2.6% | +304.2% | -1.1% | +287.5% | -1.6% | +3.1% | +16.7% | +4.3% |